CA3198014A1 — Pharmaceutical composition for oral administration of edaravone and method of administering same

USPTO Abstract

To provide a pharmaceutical composition containing edaravone as an active ingredient for oral administration or equivalent administration.A pharmaceutical composition of the present invention is characterized by containing edaravone as an active ingredient, the pharmaceutical composition being administered to a subject orally or intragastrically with any one first time interval selected from the group consisting of 1) to 3) below:1) in a case where the subject has consumed a high-fat meal, 8 hours or longer after the consumption;2) in a case where the subject has consumed a standard meal, 4 hours or longer after the consumption; and3) in a case where the subject has consumed a light meal, 2 hours or longer after the consumption.